Protamines

The main components of this product are protamine and recombinant human insulin.

Oral contraceptives, adrenal cortex hormones, thyroid hormone replacement therapy, etc. can cause blood sugar to rise. When used at the same time, the dose of insulin should be increased. Oral hypoglycemic drugs, salicylic acid preparations, sulfonamides and certain antidepressants can cause blood sugar to fall. The dose of insulin should be reduced when used at the same time. Avoid drinking alcoholic beverages.

The main ingredients of this product are protamine and recombinant human insulin.

1. Glucocorticoids, adrenocorticotropic hormone, glucagon, estrogen, oral contraceptives, thyroxine, adrenaline, thiazide diuretics, diazoxide, α2-receptor agonists, H2-receptor blockers, calcium channel blockers, clonidine, phenytoin sodium, etc. can increase blood sugar concentration. When used together, the dose of these drugs or insulin should be adjusted. 2. Oral hypoglycemic drugs and insulin have a synergistic hypoglycemic effect. 3. Anticoagulants, salicylates, sulfonamides and anti-tumor drugs such as methotrexate can compete with insulin and bind to plasma proteins, thereby increasing the level of free insulin in the blood. Non-steroidal anti-inflammatory analgesics can enhance the hypoglycemic effect of insulin. 4. α-receptor blockers such as propranolol can prevent the reaction of adrenaline to increase blood sugar, interfere with the body's blood sugar regulation function, and can increase the risk of hypoglycemia when used together with insulin, and can mask certain hypoglycemic symptoms and prolong hypoglycemia. When used together, the dose of insulin should be adjusted. 5 Chloroquine, quinidine, quinine, etc. can delay the degradation of insulin, increase the insulin concentration in the blood, and thus enhance its hypoglycemic effect. 6 Angiotensin-converting enzyme inhibitors, bromocriptine, clofibrate, ketoconazole, lithium, mebendazole, pyridoxine, theophylline, etc. can directly or indirectly affect the lowering of blood sugar in different ways. When insulin is used in combination with the above drugs, the dosage should be appropriately reduced. 7 Octreotide can inhibit the secretion of growth hormone, glucagon and insulin, and delay gastric emptying and slow gastrointestinal motility, causing delayed food absorption, thereby reducing postprandial hyperglycemia. When starting to use octreotide, the insulin dosage should be appropriately reduced and then adjusted according to blood sugar.

The main ingredients of this product are protamine and recombinant human insulin.

1. Glucocorticoids, adrenocorticotropic hormone, glucagon, estrogen, oral contraceptives, thyroxine, adrenaline, thiazide diuretics, diazoxide, α2-receptor agonists, H2-receptor blockers, calcium channel blockers, clonidine, phenytoin sodium, etc. can increase blood sugar concentration. When used together, the dose of these drugs or insulin should be adjusted. 2. Oral hypoglycemic drugs and insulin have a synergistic hypoglycemic effect. 3. Anticoagulants, salicylates, sulfonamides and anti-tumor drugs such as methotrexate can compete with insulin and bind to plasma proteins, thereby increasing the level of free insulin in the blood. Non-steroidal anti-inflammatory analgesics can enhance the hypoglycemic effect of insulin. 4. α-receptor blockers such as propranolol can prevent the reaction of adrenaline to increase blood sugar, interfere with the body's blood sugar regulation function, and can increase the risk of hypoglycemia when used together with insulin, and can mask certain hypoglycemic symptoms and prolong hypoglycemia. When used together, the dose of insulin should be adjusted. 5 Chloroquine, quinidine, quinine, etc. can delay the degradation of insulin, increase the insulin concentration in the blood, and thus enhance its hypoglycemic effect. 6 Angiotensin-converting enzyme inhibitors, bromocriptine, clofibrate, ketoconazole, lithium, mebendazole, pyridoxine, theophylline, etc. can directly or indirectly affect the lowering of blood sugar in different ways. When insulin is used in combination with the above drugs, the dosage should be appropriately reduced. 7 Octreotide can inhibit the secretion of growth hormone, glucagon and insulin, and delay gastric emptying and slow gastrointestinal motility, causing delayed food absorption, thereby reducing postprandial hyperglycemia. When starting to use octreotide, the insulin dosage should be appropriately reduced and then adjusted according to blood sugar.